Argos Therapeutics Inc (NASDAQ:ARGS) Shareholder Notice: Lawsuit Alleges Misleading Statements
An investor, who purchased shares of Argos Therapeutics Inc (NASDAQ:ARGS), filed a lawsuit in North Carolina over alleged violations of Federal Securities Laws by Argos Therapeutics Inc.
View full press release